The undersigned hereby assign all rights, included but not limited to copyright, for this manuscript to CMB Association upon its submission for consideration to publication on Cellular and Molecular Biology. The rights assigned include, but are not limited to, the sole and exclusive rights to license, sell, subsequently assign, derive, distribute, display and reproduce this manuscript, in whole or in part, in any format, electronic or otherwise, including those in existence at the time this agreement was signed. The authors hereby warrant that they have not granted or assigned, and shall not grant or assign, the aforementioned rights to any other person, firm, organization, or other entity. All rights are automatically restored to authors if this manuscript is not accepted for publication.
The Notch signaling pathway in esophageal adenocarcinoma
Corresponding Author(s) : Z Wang
zwang2@med.miami.edu
Cellular and Molecular Biology,
Vol. 61 No. 6: Advances in molecular oncology: Closer analysis of recent breakthroughs
Abstract
The Notch signaling pathway plays a critical role in embryonic development, self-renewal of stem cells, and carcinogenesis. Aberrant Notch signaling has been linked to a wide variety of cancers, and can either suppress or promote tumors depending on the cell type and the context. Increasingly it is being realized that Notch signaling not only involves in the pathogenesis and development of esophageal adenocarcinoma (EAC), it also promotes the growth of EAC cells and also involved in the maintenance of EAC cancer stem cells. The efficacy of gamma-secretase inhibitor (GSI) in EAC treatment could have a major impact on easing the burden of this devastating disease. Therefore, it appears that inhibition of Notch sensitizes EAC cells to chemotherapeutic agents, which should lead to a better and more durable response to neoadjuvant chemotherapy (NAC). In this review, we bring to highlight how Notch plays a role in the development, tumorigenicity, and stemness of EAC cells, and how Notch signaling pathway could be a promising therapeutic target for the treatment of human EAC.
Keywords
Esophageal adenocarcinoma (EAC)
Barrett's Esophagus (BE)
Notch signaling
cancer stem cells (CSCs)
gamma-secretase inhibitor (GSI).
Wang, Z., Chen, J., & Capobianco, A. J. (2015). The Notch signaling pathway in esophageal adenocarcinoma. Cellular and Molecular Biology, 61(6), 24–32. Retrieved from https://mail.cellmolbiol.org/index.php/CMB/article/view/720
Download Citation
Endnote/Zotero/Mendeley (RIS)BibTeX